Zusammenfassung
Veränderungen der Gerinnung werden im Schock beobachtet [1, 2]. Die extremste Schockform ist die Reanimationssituation. Wir haben bei sieben Patienten mit kardialem Herzkreislauf- und Atemstillstand, die auf der internistischen Intensivstation unserer Klinik reanimiert wurden, die Koagulations- und Fibrinolyseparameter im Verlauf von vier erfolgreichen und drei erfolglosen Reanimationen bestimmt.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Literatur
Matthias FR et al. (1982) Hämostaseologie 2: 26
Mittermayer Ch et al. (1978) Verh Dtsch Ges Pathol 62: 11
Gollwitzer R (1979) Thromb Res 11: 859
Bertina RM, Broekmans AW, van der Linden IK, Mertens K (1982) Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemostas 48: 1–5
Bettigole RE, Himelstein ES, Oettgen HF, Clifford GO (1970) Hypofibrinogenemia due to L-asparaginase: studies of fibrinogen survival using autologous 131I-fibrinogen. Blood 35: 195–200
Conard J, Cazenave B, Maury J, Horellou MH, Samama M (1980) L-Asparaginase, antithrombin II, and thrombosis. Lancet 1: 1091
Gralnick HR, Henderson E (1971) Hypofibrinogenemia and coagulation factor deficiencies with L-asparaginase treatment. Cancer 27: 1313–1320
Griffin JH, Evatt B, Zimmerman TS, Kleiss AJ, Wideman C (1981) Deficiency of protein C in congenital thrombotic disease. J Clin Invest 68: 1370–1373
Kisiel W (1979) Human Protein C. Isolation, characterization and mechanism of activation by a-thrombin. J Clin Invest 64: 761–769
Liebman HA, Wada JK, Patch MJ, McGehee W (1982) Depression of functional and antigenic plasma antithrombin III ( AT-III) due to therapy with L-asparaginase. Cancer 50: 451–456
Pitney WR, Phadke KP, Dean S (1980) Antithrombin III deficiency during asparaginase therapy. Lancet 1: 493–494
Priest J, Edson JR, Levitt C, Tubergen D, Steinherz P, Cairo M, Bishop A, Sitarz A, White L, Coccia P, Krivit W (1981) Thrombotic complications during L-asparaginase (L-asp)-induced deficiencies of antithrombin (AT), plasminogen (PLAS), and fibrinogen (FIB) in childhood leukemia. ASCO Abstracts, C-612
Priest JR, Ramsay NKC, Bennett AJ, Krivit W, Edson JR (1982) The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia. J Pediatr 100: 990–995
Schöndorf TH, Pralle H, Graubner M, Lasch HG (1983) Antithrombin III-deficiency and thromboembolic complications under L-asparaginase treatment. Thromb Haemostas 50: 50
Vellenga E, Mulder NH, Nieweg HO (1980) Antithrombin III deficiency during asparaginase therapy. Lancet 1: 649–650
Nurden AT, Caen JP (1974) An abnormal platelet glycoprotein pattern in three cases of Glanzmann’s thrombasthenia. Br J Haematol 28: 253
Phillips DR, Jenkins CSP, Löscher EF, Larrieu MJ (1975) Molecular differences of exposed surface proteins on thrombasthenic platelet plasma membranes. Nature 257: 599
Phillips DR, Agin PP (1977) Platelet membrane defects in Glanzmann’s thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest 60: 935
White GC, Workman EF Jr, Lundblad RL (1978) Thrombin binding to thrombastenic platelets. J Lab Clin Med 91: 76
Legrand C, Caen JP (1976) Binding of 14C-ADP by thrombastenic platelet membranes. Haemostasis 5: 231
Mustard JF, Kinlough-Rathbone RL, Packham MA, Perry DW, Harfenist EJ, Pai KRM (1979) Comparison of fibrinogen association with normal and thrombasthenic platelets on exposure to ADP or chymotrypsin. Blood 54: 987
Bennett JS, Vilaire G (1979) Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 64: 1393
Cross MJ (1964) Effect of fibrinogen on the aggregation of platelet by adenosine diphosphate. Thromb Haemostas 12: 524
McLean JR, Maxwell RE, Hertler D (1964) Fibrinogen and adenosine diphosphate-induced aggregation of platelets. Nature 202: 605
Polley MJ, Leung LVK, Clark FY, Nachman RL (1981) Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study. J Exp Med 154: 1058
Greenberg JP, Packham MA, Guccione MA, Harfenist EJ, Ork JL, Kinglough-Rathbone RL, Perry DW, Mustard JF (1979) The effect of pretreatment of human or rabbit platelets with chymotrypsin on their response to human fibrinogen and aggregating agents. Blood 54: 753
Brinkhous KM, Read MS, Mason RG (1965) Plasma thrombocyte agglutinating activity of fibrinogen. Synergism with adenosine diphosphate. Lab Invest 14: 335
Degos L, Dautigny A, Brouet JC, Colombani M, Ardaillou N, Caen JP, Colombani J (1975) A molecular defect in thrombasthenic platelets. J Clin Invest 56: 236
Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495
Santoso S, Lohmeyer J, Rennich H, Clemetson KJ, Mueller-Eckhardt C (1984) Platelet surface antigens: Analysis by monoclonal antibodies. Blut 48: 161
Santoso S: Persönliche Mitteilung
Heinrich D, Gutschank S, Mueller-Eckhardt C (1977) HLA-antibody-induced 14C-serotonin release from platelets. Vox Sang 33: 65
Kunicki TJ, Aster RH (1978) Deletion of the platelet-specific alloantigen P1A1 from platelets in Glanzmann’s thrombasthenia. J Clin Invest 61: 1225
Kunicki TJ, Aster RH (1979) Isolation and immunologic characterization of human platelet alloantigen P1A1. Mol Immunol 16: 353
Pfueller SL, Weber S, Löscher EF (1977) Studies on the mechanism of human platelets release reaction induced by immunologic stimuli. III. Relationship between the binding of soluble IgG aggregates to the Fc receptor and cell response in the presence and absence of plasma. J Immunol 118: 514
Bamberg E, Bauer O, Herrmann W, Kroemer H, Lippmann M, Müller CH, Stegmann H, Breddin KH (1978) Primärer Formwandel der Thrombozyten in vitro. Blut 37: 327–339
Bender N, Kirchmaier CM, Bartsch B, Lindenborn D, Breddin KH (1979) Stimulation of blood platelets by extracts of subcutaneous tissue. Thromb Res 14: 341–351
Kirchmaier CM, Bender N, Wilhelm B, Al Sayegh A, Breddin KH (1979) A hemostasis activating factor (HAF) in subcutaneous tissue extracts: Effects on morphologic platelet changes, platelet retention and platelet agregation. Thromb Res 16: 81–91
Kirchmaier CM, Bender N, Al Sayegh A, Breddin KH (1980) A platelet stimulating fraction in human and animal tissues. Artery 8: 416–421
Schepping M, Jäger H, Herbst MA, Rosenthal HD, Breddin KH (1982) Änderung der Volumenverteilung der Thrombozyten unter dem Einfluß von Gewebeextrakten und von thrombozytenfunktionshemmenden Medikamenten. In: van de Loo, I., Asbeck, F. (Hrsg) Haemostase, Thrombophilie und Atherosklerose. 2. Kongreß für Thrombose und Hämostase, Münster 1982. F. K. Schattauer, Stuttgart, S. 468–471
Weichert W, Pauliks V, Breddin HK (1983) Laser induced thrombi in rat mesenteric vessels and antithrombotic drugs. Haemostasis 13: 61–71
Rosenthal N, Vogel P (1937) Value of sternal puncture on the diagnosis of multiple myeloma. Mt Sinai J Med NY 4: 1001
Bernard J, Inceman S, Zara M, Christel D (1952) La dysglobulinémie maligne hémorragipare. Rev Hématol 7: 264
Pachter MR, Johnson SA, Neblett TR, Truant JP (1959) Bleeding, platelets and macroglobulinemia. Am J Clin Pathol 31: 467
Hurley R, Shaw S (1963) Observations on the haemorrhagic diathesis in multiple myeloma. Postgrad Med J 39: 480
Viala JJ, Thouverez JP, Belleville J, Revol L, Croizat P (1963) Etude de la coagulation du sang au cours des dysglobulinémies myélomes et maladie de Waldenström à propos de 48 observations. Hémostase 3: 303
Rozenberg MC, Dintenfass L (1965) Platelet aggregation in Waldenström’s macroglobulinaemia. Thromb Haemostas 14: 202
Smith E, Kochwa S, Wasserman LR (1965) Aggregation of IgG Globulin in vivo. I. The hyperviscosity syndrome in multiple myeloma. Am J Med 39: 35
Doumenc J, Prost RJ, Samama M, Bousser J (1966) Anomalie de l’aggrégation plaquettaire au cours de la maladie de Waldenström (à propos de 3 cas). Nouv Rev Fr Hematol Blood Cells 6: 734
Kopp WL, Beirne GJ, Burns RO (1967) Hyperviscosity syndrome in multiple myeloma. Am J Med 43: 141
Vigliano EW, Horowitz HI (1967) Bleeding syndrome in a patient with IgA myeloma: Interaction of protein and connective tissue. Blood 29: 823
Cohen I, Amir J, Ben-Shaul Y, Pick A, De Vries A (1970) Plasma cell myeloma associated with an unusual myeloma protein causing impairment of fibrin aggregation and platelet function in a patient with multiple malignancy. Am J Med 48: 766
Perkins HA, McKenzie MR, Fudenberg HH (1970) Hemostatic defects in dysproteinaemias. Blood 35: 695
Benninger GW, Kreps SI (1971) Aggregation phenomenon in an IgG multiple myeloma resulting in the hyperviscosity syndrome. Am J Med 51: 287
Penny R, Castaldi PA, Whitsed HM (1971) Inflammation and haemostasis in paraproteinaemias. Br J Haematol 20: 35
Pruzanski W, Watt JG (1972) Serum viscosity and hyperviscosity syndrome in IgG multiple myeloma. Ann Intern Med 77: 853
Tuddenham EGD, Whittaker JA, Bradley J, Lilleyman JS, James DR (1974) Hyperviscosity syndrome in IgA multiple myeloma. Br J Haematol 27: 65
Harbaugh ME, Hill EM, Conn RB (1975) Antithrombin and antithromboplastin activity accompanying IgG myeloma. Am J Clin Pathol 63: 57
Deutsch E, Neumann E, Niessner H (1976) Zur Pathogenese der hämorrhagischen Diathesen bei monoklonalen Gammopathien. In: Löffler H (Hrsg) Maligne Lymphome und monoklonale Gammopathien, Reihe: Hämatologie und Bluttransfusion, Bd 18. JF Lehmanns, München, S. 357
Roberts-Thomson PJ, Mason DY, Mac Lennan ICM (1976) Relationship between paraprotein polymerization and clinical features in IgA myeloma. Br J Haematol 33: 117
Kasturi J, Saraya AK (1978) Platelet functions in dysproteinaemia. Acta Haematol (Basel) 59: 104
McGrath KM, Stuart JJ, Richards F (1979) Correlation between serum-IgG, platelet membrane IgG and platelet function in hypergammaglobulinaemic states. Br J Haematol 42: 585
Hedge UM, Powell DK, Bowes A, Gordon-Smith EC (1981) Enzyme linked immunoassay for the detection of platelet associated IgG. Br J Haematol 48: 39
Landolfi R, Leone G, Fedeli G, Storti S, Laghi F, Bizzi B (1980) Platelet associated IgG in acute and chronic hepatic diseases. Scand J Haematol 25: 417
Mueller-Eckhardt C, Kayser W, Mersch-Baumert K, Mueller-Eckhardt G, Breidenbach M, Kugel H-G, Graubner M (1980) The clinical significance of platelet associated IgG: a study on 298 patients with various disorders. Br J Haematol 46: 123
Kayser W (1981) Immunoglobulin G und Komplementfaktoren an menschlichen Thrombozyten: Pathogenetische, diagnostische und klinische Aspekte. Inaug.-Diss. Gießen
Morse BS, Ginliani D, Nussbaum M (1981) Quantitation of Platelet-associated IgG by radial immunodiffusion. Blood 57: 809
Hedge UM, Williams K, Devereux S, Bowes A (1983) Platelet associated IgG and immune thrombocytopenia in lymphoproliferative and autoimmune disorders. Clin Lab Haematol 5: 9
Kelton JG, Giles AR, Neam PB, Powers P, Hageman N, Hirsh J (1980) Comparison of two direct assays for PAIgG in assessment of immune and nonimmune thrombocytopenia. Blood 55: 424
Kelton JG, Steeves K (1983) The amount of platelet-bound albumin parallels the amount of IgG on washed platelets from patients with immune thrombocytopenia. Blood 62: 924
Shulman NR, Leisinger CA, Hotchkiss AJ, Kautz CA (1983) The nonspecific nature of platelet-associated IgG. Trans Assoc Am Physicians 95: 213
Mueller-Eckhardt C, Schulz G, Sauer K-H, Dienst C, Mahn J (1978) Studies on the platelet radioactive immunoglobulin test. J Immunol Methods 19: 1
Mueller-Eckhardt C, Mueller-Eckhardt G, Kayser W, Voss RM, Wegner J, Kiienzlen E (1982) Platelet associated IgG, platelet survival, and platelet sequestration in thrombocytopenic states. Br J Haematol 52: 49
McGregor JL, Brochier J, Wild F, Follea G, Trzeciak MC, James E, Dechavanne M, McGregor L, Clemetson KJ (1983) Monoclonal antibodies against platelet membrane glycoproteins. Characterization and effect on platelet function. Eur J Biochem 131: 427
Scharf T, Santoso S, Rennich H, Heinrich D, Mueller-Eckhardt C (1984) Einfluß monoklonaler, Glykoprotein llb/Ills-and Zw(a)-spezifischer Antikörper auf die Plättchenfunktion. Blut (im Druck )
Born GVR, Cross MI (1963) The aggregation of blood platelets. J Physiol 168: 178–195
Breddin K, Bürck KH (1963) Zur Klinik der Thrombozytenfunktionsstörungen unter besonderer Berücksichtigung der Ausbreitungsfähigkeit der Thrombozyten an silikonisierten Glasflächen. Thromb Haemostas 9: 525–545
Crea F, Chierchia R, Caterina R de, Bernini W, Giannesi, Maseri A (1981) Antiplatelet effects of isosorbide dinitrate ( ISDN) in man. Eur Heart J (Suppl A) 2: 53
Levin RI, Jaffe EA, Weksler BB, Tack-Goldmann K (1981) Nitroglycerin stimulates synthesis of prostacyclin by cultured human endothelial cells. J Clin Invest 67: 762–769
Ring T, Knudsen F, Kristensen SD, Larsen CE (1983) Nitroglycerin prolongs the bleeding time in healthy males. Thromb Res 29: 553–559
Schafer AI, Alexander RW, Handin RI (1980) Inhibition of platelet function by organic nitrate vasodilatators. Blood 55: 649–654
Schrör K, Grodzinska L, Darius H (1981) Stimulation of coronary vascular prostacyclin and inhibition of human platelet thromboxane A2 after low dose nitroglycerin. Thromb Res 23: 59–67
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Klaubert, W. et al. (1984). Hämostaseologie. In: 90. Kongreß. Verhandlungen der Deutschen Gesellschaft für Innere Medizin, vol 90. J.F. Bergmann-Verlag, Munich. https://doi.org/10.1007/978-3-642-85457-6_28
Download citation
DOI: https://doi.org/10.1007/978-3-642-85457-6_28
Publisher Name: J.F. Bergmann-Verlag, Munich
Print ISBN: 978-3-8070-0342-9
Online ISBN: 978-3-642-85457-6
eBook Packages: Springer Book Archive